(GPAT) GP-Act III Acquisition - Ratings and Ratios
Merger, Acquisition, Financial, Services, Shares
GPAT EPS (Earnings per Share)
GPAT Revenue
Description: GPAT GP-Act III Acquisition
GP-Act III Acquisition Corp. is a special purpose acquisition company (SPAC) that aims to merge with or acquire a business through a share exchange, asset acquisition, or similar business combination. The companys primary objective is to identify a suitable target and facilitate a business combination.
From a financial perspective, GPAT has a market capitalization of $379.86 million, indicating a moderate size. The price-to-earnings (P/E) ratio of 33.03 suggests that the stock may be relatively expensive compared to its earnings. The return on equity (RoE) of 5.65% is relatively modest, implying that the companys financial performance is not exceptionally strong. To further evaluate the companys financial health, we can examine additional key performance indicators (KPIs) such as debt-to-equity ratio, current ratio, and operating cash flow margin.
Further analysis reveals that GPAT operates in the Diversified Financial Services industry, which is a broad category. As a SPAC, the companys success is heavily dependent on its ability to identify and execute a successful business combination. To assess the companys potential, we can examine its management teams track record, the industry trends, and the competitive landscape. Key metrics to monitor include the companys cash holdings, warrant coverage, and the terms of its proposed business combination.
To make an informed investment decision, its essential to evaluate GPATs potential for growth, its valuation, and the risks associated with its business model. Additional KPIs to consider include the companys enterprise value-to-EBITDA (EV/EBITDA) ratio, the return on assets (RoA), and the dividend yield (if applicable). By examining these metrics, we can gain a more comprehensive understanding of GPATs investment potential and make a more informed decision.
Additional Sources for GPAT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
GPAT Stock Overview
Market Cap in USD | 380m |
Sector | Financial Services |
Industry | Shell Companies |
GiC Sub-Industry | Diversified Financial Services |
IPO / Inception | 2024-07-01 |
GPAT Stock Ratings
Growth Rating | 48.2 |
Fundamental | -2.19 |
Dividend Rating | 0.0 |
Rel. Strength | -12.9 |
Analysts | - |
Fair Price Momentum | 9.97 USD |
Fair Price DCF | - |
GPAT Dividends
Currently no dividends paidGPAT Growth Ratios
Growth Correlation 3m | 72.7% |
Growth Correlation 12m | 98.7% |
Growth Correlation 5y | 98.8% |
CAGR 5y | 5.21% |
CAGR/Max DD 5y | 7.65 |
Sharpe Ratio 12m | -1.58 |
Alpha | 1.05 |
Beta | 0.012 |
Volatility | 2.85% |
Current Volume | 220.2k |
Average Volume 20d | 0.1k |
Stop Loss | 10.2 (-3.4%) |
As of August 03, 2025, the stock is trading at USD 10.56 with a total of 220,195 shares traded.
Over the past week, the price has changed by -0.33%, over one month by +0.14%, over three months by +1.49% and over the past year by +5.39%.
Neither. Based on ValueRay´s Fundamental Analyses, GP-Act III Acquisition is currently (August 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -2.19 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of GPAT is around 9.97 USD . This means that GPAT is currently overvalued and has a potential downside of -5.59%.
GP-Act III Acquisition has no consensus analysts rating.
According to our own proprietary Forecast Model, GPAT GP-Act III Acquisition will be worth about 10.8 in August 2026. The stock is currently trading at 10.56. This means that the stock has a potential upside of +1.99%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 10.8 | 2% |